TNIP2_HUMAN - dbPTM
TNIP2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TNIP2_HUMAN
UniProt AC Q8NFZ5
Protein Name TNFAIP3-interacting protein 2
Gene Name TNIP2 {ECO:0000312|EMBL:EAW82514.1}
Organism Homo sapiens (Human).
Sequence Length 429
Subcellular Localization Cytoplasm . Nucleus .
Protein Description Inhibits NF-kappa-B activation by blocking the interaction of RIPK1 with its downstream effector NEMO/IKBKG. Forms a ternary complex with NFKB1 and MAP3K8 but appears to function upstream of MAP3K8 in the TLR4 signaling pathway that regulates MAP3K8 activation. Involved in activation of the MEK/ERK signaling pathway during innate immune response; this function seems to be stimulus- and cell type specific. Required for stability of MAP3K8. Involved in regulation of apoptosis in endothelial cells; promotes TEK agonist-stimulated endothelial survival. May act as transcriptional coactivator when translocated to the nucleus. Enhances CHUK-mediated NF-kappa-B activation involving NF-kappa-B p50-p65 and p50-c-Rel complexes..
Protein Sequence MSRDPGSGGWEEAPRAAAALCTLYHEAGQRLRRLQDQLAARDALIARLRARLAALEGDAAPSLVDALLEQVARFREQLRRQEGGAAEAQMRQEIERLTERLEEKEREMQQLLSQPQHEREKEVVLLRRSMAEGERARAASDVLCRSLANETHQLRRTLTATAHMCQHLAKCLDERQHAQRNVGERSPDQSEHTDGHTSVQSVIEKLQEENRLLKQKVTHVEDLNAKWQRYNASRDEYVRGLHAQLRGLQIPHEPELMRKEISRLNRQLEEKINDCAEVKQELAASRTARDAALERVQMLEQQILAYKDDFMSERADRERAQSRIQELEEKVASLLHQVSWRQDSREPDAGRIHAGSKTAKYLAADALELMVPGGWRPGTGSQQPEPPAEGGHPGAAQRGQGDLQCPHCLQCFSDEQGEELLRHVAECCQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSRDPGSGG
------CCCCCCCCC
45.45-
7Phosphorylation-MSRDPGSGGWEEAP
-CCCCCCCCCCCHHH
39.2523401153
22PhosphorylationRAAAALCTLYHEAGQ
HHHHHHHHHHHHHHH
31.0721712546
24PhosphorylationAAALCTLYHEAGQRL
HHHHHHHHHHHHHHH
4.5821712546
62PhosphorylationLEGDAAPSLVDALLE
HHCCCCHHHHHHHHH
35.9830108239
113PhosphorylationREMQQLLSQPQHERE
HHHHHHHCCCHHHHH
48.7024043423
121UbiquitinationQPQHEREKEVVLLRR
CCHHHHHHHHHHHHH
63.13-
129PhosphorylationEVVLLRRSMAEGERA
HHHHHHHHHHHHHHH
18.86-
140PhosphorylationGERARAASDVLCRSL
HHHHHHHHHHHHHHH
27.5427251275
146PhosphorylationASDVLCRSLANETHQ
HHHHHHHHHHHHHHH
30.7330108239
170UbiquitinationHMCQHLAKCLDERQH
HHHHHHHHHHHHHHH
41.51-
186PhosphorylationQRNVGERSPDQSEHT
HHCCCCCCCCCCCCC
28.6423401153
190PhosphorylationGERSPDQSEHTDGHT
CCCCCCCCCCCCCCC
38.4323663014
193PhosphorylationSPDQSEHTDGHTSVQ
CCCCCCCCCCCCHHH
39.3623663014
197PhosphorylationSEHTDGHTSVQSVIE
CCCCCCCCHHHHHHH
35.8029255136
198PhosphorylationEHTDGHTSVQSVIEK
CCCCCCCHHHHHHHH
16.6929255136
201PhosphorylationDGHTSVQSVIEKLQE
CCCCHHHHHHHHHHH
23.9429255136
205UbiquitinationSVQSVIEKLQEENRL
HHHHHHHHHHHHCHH
44.33-
279UbiquitinationINDCAEVKQELAASR
HHHHHHHHHHHHHHH
29.56-
330UbiquitinationRIQELEEKVASLLHQ
HHHHHHHHHHHHHHH
33.45-
333PhosphorylationELEEKVASLLHQVSW
HHHHHHHHHHHHHHC
34.1630108239
339PhosphorylationASLLHQVSWRQDSRE
HHHHHHHHCCCCCCC
15.2427273156
344PhosphorylationQVSWRQDSREPDAGR
HHHCCCCCCCCCCCC
30.1526699800
356PhosphorylationAGRIHAGSKTAKYLA
CCCCCCCHHHHHHHH
27.8427273156
357UbiquitinationGRIHAGSKTAKYLAA
CCCCCCHHHHHHHHH
52.14-
361PhosphorylationAGSKTAKYLAADALE
CCHHHHHHHHHHHHH
10.1027642862
413PhosphorylationPHCLQCFSDEQGEEL
CCHHHHCCHHHHHHH
48.1130108239

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseSMURF1Q9HCE7
PMID:20804422

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TNIP2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TNIP2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TNAP3_HUMANTNFAIP3physical
21266526
M3K8_HUMANMAP3K8physical
15169888
NFKB1_HUMANNFKB1physical
15169888
NEMO_HUMANIKBKGphysical
14653779
IKKA_HUMANCHUKphysical
21784860
IKKB_HUMANIKBKBphysical
21784860
SMRD1_HUMANSMARCD1physical
12753905
TIE2_HUMANTEKphysical
12609966
STK11_HUMANSTK11physical
12595760
A4_HUMANAPPphysical
21832049
UBC_HUMANUBCphysical
19373254
UBC_HUMANUBCphysical
27916521
UBP35_HUMANUSP35physical
26348204

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TNIP2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND MASSSPECTROMETRY.

TOP